Auxilium Pharmaceuticals Inc. (AUXL)
-NasdaqGS 17.21 
0.13(0.75%) 10:11AM EDT - Nasdaq Real Time Price
| Prev Close: | 17.34 |
|---|
| Open: | 17.32 |
|---|
| Bid: | 17.15 x 200 |
|---|
| Ask: | 17.20 x 300 |
|---|
| 1y Target Est: | 21.57 |
|---|
| Beta: | 0.79 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 17.13 - 17.37 |
|---|
| 52wk Range: | 13.87 - 29.37 |
|---|
| Volume: | 25,465 |
|---|
| Avg Vol (3m): | 803,314 |
|---|
| Market Cap: | 847.73M |
|---|
| P/E (ttm): | 10.71 |
|---|
| EPS (ttm): | 1.60 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- What's behind put buying in AuxiliumoptionMONSTER(Mon, Jun 17)
- Coverage initiated on Auxilium Pharma by MizuhoBriefing.com(Thu, Jun 13)
- Commit To Buy Auxilium Pharmaceuticals At $12.50, Earn 15.3% Annualizedat Forbes(Thu, Jun 13)
- Identifying the Biggest Gem in Antares's Pipelineat Motley Fool(Thu, Jun 13)
- AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements andEDGAR Online(Thu, Jun 13)
- Men's Health Network And Auxilium Pharmaceuticals, Inc. Mark Men's Health Month With "Ask About The Curve™" Collaboration To Encourage Greater Understanding Of Peyronie's DiseasePR Newswire(Tue, Jun 11)
- AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, Jun 11)
- Auxilium Pharmaceuticals, Inc. To Present At The Goldman Sachs 34th Annual Global Healthcare ConferencePR Newswire(Fri, Jun 7)
- Auxilium upgraded to Outperform from Market Perform at Leerinkat theflyonthewall.com(Wed, Jun 5)
- The Third Time Is Not the Charm for Endo Health Solutionsat Motley Fool(Sat, Jun 1)
- Auxilium Pharmaceuticals, Inc. To Present At The Jefferies 2013 Healthcare ConferencePR Newswire(Fri, May 31)
- AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Wed, May 29)
- Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care ConferencePR Newswire(Fri, May 24)
- AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, May 21)
- Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care ConferencePR Newswire(Wed, May 15)
Key Statistics
| Forward P/E (1 yr): | 28.60 |
|---|
| P/S (ttm): | 2.20 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.13 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.04 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | -4.46 |
|---|
Business Summary
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, develops and markets pharmaceutical products worldwide.
View More